Robert Dee Etherington
Chief Executive Officer at CLENE INC.
Net worth: 40 082 $ as of 31/03/2024
Profile
Robert Dee Etherington is currently the President, Chief Executive Officer & Director at Clene Nanomedicine, Inc. and Clene, Inc. He is also a Director at BioUtah and Corsair LLC.
Previously, he worked as the Marketing Director at Actelion Pharmaceuticals Ltd.
from 2000 to 2013.
Mr. Etherington completed his undergraduate degree at Brigham Young University in 1990 and obtained an MBA in 1992.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CLENE INC
0.07% | 01/04/2024 | 94,310 ( 0.07% ) | 40 082 $ | 31/03/2024 |
Robert Dee Etherington active positions
Companies | Position | Start |
---|---|---|
CLENE INC. | Chief Executive Officer | 01/04/2013 |
BioUtah | Director/Board Member | 01/06/2016 |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Chief Executive Officer | 01/04/2013 |
Corsair LLC | Director/Board Member | 01/03/2018 |
Former positions of Robert Dee Etherington
Companies | Position | End |
---|---|---|
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The private company is based in Allschwil, Switzerland. | Sales & Marketing | 01/03/2013 |
Training of Robert Dee Etherington
Brigham Young University | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CLENE INC. | Health Technology |
Private companies | 4 |
---|---|
BioUtah | |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The private company is based in Allschwil, Switzerland. | Health Technology |
Corsair LLC |
- Stock Market
- Insiders
- Robert Dee Etherington